Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJohnson Matthey Regulatory News (JMAT)

Share Price Information for Johnson Matthey (JMAT)

Share Price is delayed by 15 minutes
Get Live Data
2,080.00    -62.00 (-2.89%)
Bid:
2,066.00
Ask:
2,070.00
Spread: 4.00 (0.194%)
Market Cap: £3.48b
JMAT Live PriceLast checked at - London Stock Exchange

Intraday Johnson Matthey Share Chart

Share buyback programme

14 Feb 2022 07:00

RNS Number : 5097B
Johnson Matthey PLC
14 February 2022
 

14th February 2022

 

Johnson Matthey Plc

Share buyback programme

 

On 24th November 2021, Johnson Matthey Plc ("JM" or the "Company") announced its intention to conduct a share buyback programme of its ordinary shares up to a maximum consideration of £200m.

 

The first tranche of the share buyback programme of up to £100m commenced on 21st December 2021 and completed on 28th January 2022, in accordance with its terms.

 

The Company announces that the second tranche of the share buyback programme of up to £100m (the "Programme") will commence today and will end no later than 20th May 2022.

The Company has entered into an irrevocable, non-discretionary agreement with Citigroup Global Markets Ltd ("Citi") to manage the Programme, pursuant to which Citi will purchase Johnson Matthey ordinary shares (acting as principal) for subsequent repurchase by the Company. Citi will make trading decisions under the Programme independently of JM. Purchases may continue during any closed period to which the Company is subject.

 

The sole purpose of the Programme is to reduce the share capital of the Company. All shares repurchased under the Programme will be cancelled.

 

The maximum number of shares that may be repurchased under the Programme is 19,353,343 shares, being the number of shares the Company is authorised to purchase pursuant to the authority granted by shareholders at the Company's 2021 Annual General Meeting (the "2021 AGM"), less the number of shares that have already been repurchased pursuant to that authority.

Any purchase of the Company's ordinary shares in relation to this announcement will be effected within certain pre-set parameters and in accordance with JM's general authority to repurchase ordinary shares granted by its shareholders at the 2021 AGM, the Market Abuse Regulation 596/2014 (as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018), and Chapter 12 of the Financial Conduct Authority's Listing Rules. No repurchases will be made in respect of the Company's American Depositary Receipts.

 

ENDS

 

Enquiries: 

 

 

 

Martin Dunwoodie

Victoria Barlow

 

Director of Investor Relations

Deputy Company Secretary

 

+44 20 7269 8241

+44 20 7269 8431

 

 

 

 

 

 

 

 

 

 

Johnson Matthey Plc is listed on the London Stock Exchange (JMAT)

Registered in England & Wales number: 00033774Legal Entity Identifier number: 2138001AVBSD1HSC6Z10 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSBKNBDKBKBNBD
Date   Source Headline
15th Aug 201811:22 amRNSDirector/PDMR Shareholding
15th Aug 201811:11 amRNSDirector/PDMR Shareholding
9th Aug 20182:53 pmRNSDirector/PDMR Shareholding
9th Aug 20182:20 pmRNSDirector/PDMR Shareholding
9th Aug 20182:17 pmRNSDirector/PDMR Shareholding
8th Aug 20184:09 pmRNSDirector/PDMR Shareholding
3rd Aug 20182:01 pmRNSDirector/PDMR Shareholding
3rd Aug 20182:00 pmRNSDirector/PDMR Shareholding
2nd Aug 20184:11 pmRNSDirector/PDMR Shareholding
2nd Aug 20184:10 pmRNSDirector/PDMR Shareholding
2nd Aug 20184:06 pmRNSDirector/PDMR Shareholding
26th Jul 20182:58 pmRNSResult of AGM
26th Jul 20187:00 amRNSAGM trading update
19th Jul 20185:34 pmRNSHolding(s) in Company
19th Jul 20184:24 pmRNSDirector/PDMR Shareholding
12th Jul 20182:20 pmRNSHolding(s) in Company
25th Jun 20184:04 pmRNSHolding(s) in Company
21st Jun 201812:12 pmRNSDirector/PDMR Shareholding
20th Jun 20187:00 amRNSAnnual Financial Report
31st May 20187:00 amRNSPreliminary results for year ended 31st March 2018
17th May 20183:29 pmRNSDirector/PDMR Shareholding
19th Apr 20184:41 pmRNSDirector/PDMR Shareholding
16th Apr 20187:25 amRNSDirectorate Change
23rd Mar 20182:18 pmRNSDirector/PDMR Shareholding
22nd Mar 20182:48 pmRNSDirector/PDMR Shareholding
5th Mar 20187:00 amRNSResult of the External Audit Tender
2nd Mar 20187:00 amRNSAppointment of Sector Chief Executive, Health
22nd Feb 201812:16 pmRNSDirector/PDMR Shareholding
9th Feb 20189:39 amRNSDirector/PDMR Shareholding
8th Feb 20184:48 pmRNSDirector/PDMR Shareholding
8th Feb 20184:43 pmRNSDirector/PDMR Shareholding
8th Feb 20184:41 pmRNSDirector/PDMR Shareholding
7th Feb 20187:00 amRNSJohnson Matthey business update
31st Jan 20181:00 pmRNSJM and Cummins Expand Efforts in Electrification
18th Jan 20182:12 pmRNSDirector/PDMR Shareholding
21st Dec 201710:17 amRNSDirector/PDMR Shareholding
22nd Nov 201712:20 pmRNSDirector/PDMR Shareholding
21st Nov 20177:00 amRNSHalf year results
16th Nov 201712:37 pmRNSDirector/PDMR Shareholding
20th Oct 20179:07 amRNSColin Matthews - New Directorship
19th Oct 20174:29 pmRNSDirector/PDMR Shareholding
22nd Sep 20172:12 pmRNSDirector/PDMR Shareholding
21st Sep 20177:00 amRNSCapital Markets Day Statement
18th Aug 201711:38 amRNSDirector/PDMR Shareholding
18th Aug 201711:34 amRNSDirector/PDMR Shareholding
18th Aug 201711:26 amRNSDirector/PDMR Shareholding
17th Aug 20175:00 pmRNSHolding(s) in Company
17th Aug 20173:33 pmRNSDirector/PDMR Shareholding
4th Aug 20172:14 pmRNSDirector/PDMR Shareholding
3rd Aug 20173:59 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.